22246-18-0O=C1CCc2ccc(O)cc2N1LKLSFDWYIBUGNT-UHFFFAOYSA-N22246-18-0DTXSID70382941CHEMBL2430711CHEBI:228791This chemical does not meet GHS hazard criteria for 2% (1 of 51) of reports.
Warning
H302 (84.3%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (11.8%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (82.4%): May cause an allergic skin reaction [Warning Sensitization, Skin];H319 (13.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (11.8%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 51 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 1 of 51 reports by companies.;There are 6 notifications provided by 50 of 51 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Description3,4-Dihydro-7-hydroxy-2 (1H)-quinolinone is a useful organic and pharmaceutical intermediate. It can be used as the precursor of aripiprazole1, which is an antipsychotic medication. It is also an antitumor agent and hydroxyindole analog inhibitor tyrosinase melanoma.
Uses3,4-Dihydro-7-hydroxyquinoline-2(1H)-one (Aripiprazole EP Impurity A) is an antitumor agent. Hydroxyindole analog inhibitor tyrosinase melanoma. This compound is also used in the preparation of aripiprazole (A771000).
Loading…